Apheresis
Showing 1 - 25 of 1,019
Vascular Access Complications for Therapeutic Apheresis in
Recruiting
- Vascular Access Complication
- Apheresis Related Complication
-
Nancy, FranceCentral Hospital
May 30, 2023
Healthy Subjects Trial in El Segundo (N-803)
Not yet recruiting
- Healthy Subjects
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Sep 14, 2023
Citrate Effects and Bone Density in Long-Term Apheresis Donors
Completed
- Healthy Apheresis Donors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 22, 2022
Fatigue, Post-Acute COVID-19 Syndrome Trial in Hannover (Immunoadsorption vs. sham immunoadsorption)
Not yet recruiting
- Fatigue
- Post-Acute COVID-19 Syndrome
- Immunoadsorption vs. sham immunoadsorption
-
Hannover, Lower Saxony, GermanyHannover Medical School
Jul 24, 2023
LDL-Apheresis for FSGS CardioRenal Outcomes
Enrolling by invitation
- Focal Segmental Glomerulosclerosis
- No intervention
-
Cincinnati, Ohio
- +1 more
Jan 25, 2023
Hypercholesterolemia, Familial, Dyslipidemias, Cardiovascular Diseases Trial in Rostock, Dresden (Lipoprotein Apheresis MONET
Completed
- Hypercholesterolemia, Familial
- +2 more
- Lipoprotein Apheresis MONET and DALI
- Lipoprotein Apheresis DIAMED and DALI
-
Rostock, Mecklenburg-Vorpommern, Germany
- +1 more
Jul 27, 2022
Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and
Recruiting
- Granuloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Tolerance of Therapeutic Apheresis in Paediatric
Completed
- Apheresis Related Complication
- Efficacy of apheresis
-
Montpellier, FranceUh Montpellier
Apr 11, 2022
Stroke, Ischemic Trial in Ulm (CRP apheresis)
Recruiting
- Stroke, Ischemic
- CRP apheresis
-
Ulm, Bayern, GermanyAbteilung für Neurologie, Universität Ulm
Mar 8, 2022
ST Elevation Myocardial Infarction, C-Reactive Protein, Apheresis Trial in Austria, Germany (Selective CRP apheresis using the
Recruiting
- ST Elevation Myocardial Infarction
- +3 more
- Selective CRP apheresis using the PentraSorb®-CRP system
-
Graz, Austria
- +4 more
Jul 11, 2022
Fluid Loss Trial in Denver (CM-1500)
Recruiting
- Fluid Loss
- CM-1500
-
Denver, ColoradoVitalant Blood Donation
Jun 3, 2022
Apheresis of Patients With Immunodeficiency
Recruiting
- LAD-1
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Two is Better Than One: A Novel Venous Access System for
Recruiting
- Apheresis
- PowerPort
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Apr 26, 2022
Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)
Terminated
- Decreased Immunologic Activity
- Antibody-mediated Rejection
- Combined apheresis
-
Vienna, AustriaDivision of Medicine III, Dpt. of Nephrology and Dialysis, Medic
Aug 22, 2022
Stroke, Ischemic Trial in Berlin (CRP apheresis)
Recruiting
- Stroke, Ischemic
- CRP apheresis
-
Berlin, GermanyZentrum für Schlaganfallforschung (CSB) / Klinik für Neurologie
Mar 24, 2022
Healthy Trial (BioCaptis)
Not yet recruiting
- Healthy
- BioCaptis
- (no location specified)
Apr 12, 2023
Bone Density Trial in Milwaukee (high frequency voluntary apheresis blood donation)
Completed
- Bone Density
- high frequency voluntary apheresis blood donation
-
Milwaukee, WisconsinBloodCenter of Wisconsin
Mar 8, 2022
Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)
Recruiting
- Allogeneic Granulocyte Donation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
Hypertriglyceridemia-associated Acute Pancreatitis: Apheresis
Completed
- Acute Pancreatitis
- conservative versus plasmapharesis therapy
-
Kfar Saba, IsraelMeir Medical Center
Apr 12, 2022
Plasma Exchange Trial in Dallas (20-gauge BD Nexiva Diffusics)
Completed
- Plasma Exchange
- 20-gauge BD Nexiva Diffusics
-
Dallas, TexasZale Lipshy Pavilion
May 11, 2022
Covid19 Trial in Germany (CRP-apheresis)
Recruiting
- Covid19
- CRP-apheresis
-
Essen, NRW, Germany
- +3 more
Mar 29, 2022
Hyperlipoproteinemia(a) Trial (Pelacarsen (TQJ230) 80 mg s.c., Corresponding Placebo)
Not yet recruiting
- Hyperlipoproteinemia(a)
- Pelacarsen (TQJ230) 80 mg s.c.
- Corresponding Placebo
- (no location specified)
Mar 22, 2022
Blood Components From Healthy Donors for In Vitro Research Use
Recruiting
- Blood Donors
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Apheresis Related Hypotension Trial in Lakeland, West Des Moines, American Fork (Aurora Xi New Nomogram Software 2.0, Aurora Xi
Not yet recruiting
- Apheresis Related Hypotension
- Aurora Xi New Nomogram Software 2.0
- Aurora Xi Currently Approved Software 1.3
-
Lakeland, Florida
- +2 more
Nov 3, 2023
Lipoproteinemia, Apheresis Related Complication, Cardiovascular Diseases Trial in Dresden (Dextran sulfate absorption
Recruiting
- Lipoproteinemia
- +2 more
- Dextran sulfate absorption (LIPOSORBER® D - Kaneka Pharma Europe NV)
- +3 more
-
Dresden, GermanyCarl Gustav Carus University Hospital Dresden, Technische Univer
Dec 20, 2021